| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/25/2011 | US7877213 System and methods for automated processing of multiple chemical arrays |
| 01/25/2011 | US7877212 Methods and compositions for assessing partially saturated pixel signals |
| 01/25/2011 | US7876094 Magnetic field characterization of stresses and properties in materials |
| 01/25/2011 | US7875733 Oligomeric compounds comprising 4′-thionucleosides for use in gene modulation |
| 01/25/2011 | US7875713 Synthetic binding pairs comprising cucurbituril derivatives and polyammonium compounds and uses thereof |
| 01/25/2011 | US7875710 Nucleic acids encoding platelet derived growth factor receptor alpha (PDGFRA) activating mutations |
| 01/25/2011 | US7875604 Compounds that inhibit HIV particle formation |
| 01/25/2011 | US7875586 Treatment of metastatic colon cancer with b-subunit of shiga toxin |
| 01/25/2011 | US7875585 Hematopoietic cell E-selectin / L-selectin ligand glycosylated CD44 polypeptide |
| 01/25/2011 | US7875467 Chemiluminescence; quantitative analysis of macromolecules; complexing sample to acridinium compound, labels for improving sensitivity of immunoassays, 2',6'-dimethyl-4'-N-succinimidyloxycaproyl-amidocarbonylphenyl-N10-2,7-tris[O-methoxyhexa(ethylene) glycol-sulfonamidylpropyl]-acridinium-9-carboxylate |
| 01/25/2011 | US7875466 coated with phosphor fluoride via dispersing nanoparticle and aqueous fluoride-containing compound in deionized water, contacting mixture with aqueous solution containing soluble salts of phosphor host, absorber-emitter pair, and rare-earth metal chelator by stirring to allow precipitate |
| 01/25/2011 | US7875465 Target substance capturing molecule |
| 01/25/2011 | US7875464 Processing and analysis techniques involving in-vessel material generation |
| 01/25/2011 | US7875463 Generalized pulse jet ejection head control model |
| 01/25/2011 | US7875461 Test strip and connector |
| 01/25/2011 | US7875460 Method for determining the effectiveness of stabilized chlorine dioxide in a mouth rinse |
| 01/25/2011 | US7875458 Application of test for residual wax contamination in basestocks to correlate with the low temperature viscometric properties of fully formulated oils |
| 01/25/2011 | US7875455 Real time oil reservoir evaluation using nanotechnology |
| 01/25/2011 | US7875450 Virus-like particles for the induction of autoantibodies |
| 01/25/2011 | US7875435 Diagnostic testing process |
| 01/25/2011 | US7875434 Label-free methods for performing assays using a colorimetric resonant reflectance optical biosensor |
| 01/25/2011 | US7875433 Comparative multiple analyte assay |
| 01/25/2011 | US7875431 in gastrointestinal tissues or cells of mammal by detecting increased expression of LY6 genes |
| 01/25/2011 | US7875421 determining probiotic properties |
| 01/25/2011 | US7875324 Biological laser printing via indirect photon-biomaterial interactions |
| 01/25/2011 | US7875259 Generating prion specific immunoglobulin for use in diagnosis, prevention and treatment of neurodegenerative disorders |
| 01/25/2011 | US7875244 shock resistance, temperature resistance; combustion chambers, glass fiber mat supports |
| 01/25/2011 | US7875239 Sterilizer test device |
| 01/25/2011 | US7875164 In situ self-calibrating method for electrochemical sensor to measure dissolved oxygen; sensor includes working electrode of micro-disc type and its counter electrode; reference electrode connected to potentiostat and generating electrode of diamond doped with boron; self-cleaning; sewage treatment |
| 01/25/2011 | US7875047 Method and apparatus for a multi-use body fluid sampling device with sterility barrier release |
| 01/25/2011 | US7874994 Method and apparatus for penetrating tissue |
| 01/25/2011 | US7874985 Method, system, and computer program product for the evaluation of glycemic control in diabetes from self-monitoring data |
| 01/25/2011 | US7874481 Method of maintaining product status |
| 01/25/2011 | CA2635963C Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof |
| 01/25/2011 | CA2614579C Apparatus for warming entrained gases from recovered wellbore fluid samples |
| 01/25/2011 | CA2534470C Filter snapper |
| 01/25/2011 | CA2529579C Biosensor with multiple electrical functionalities |
| 01/25/2011 | CA2526847C Assay and kits for detecting protein binding |
| 01/25/2011 | CA2525499C Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells |
| 01/25/2011 | CA2471462C Internal calibration system for flow-through assays |
| 01/25/2011 | CA2470512C Apparatus and methods for downhole determination of characteristics of formation fluids |
| 01/25/2011 | CA2462649C System for the detection of urease and method for using same |
| 01/25/2011 | CA2453278C Diagnostic agents for pancreatic exocrine function |
| 01/25/2011 | CA2424611C Identification of protein binding sites |
| 01/25/2011 | CA2423068C Acoustic ejection of fluids from a plurality of reservoirs |
| 01/25/2011 | CA2417648C Inactivation of antimicrobial agents by a phospholipid or a nonionic surfactant in methods of quantifying microorganisms |
| 01/25/2011 | CA2389829C Biological fluid constituent sampling and measurement devices and methods |
| 01/25/2011 | CA2382931C Synthesis of template-fixed .beta.-hairpin loop mimetics |
| 01/25/2011 | CA2381038C Measurement of analytes in whole blood |
| 01/25/2011 | CA2378519C Human cytokine receptor |
| 01/25/2011 | CA2344467C Ucp4 |
| 01/25/2011 | CA2321089C Human homolog of the drosophila protein "fused" |
| 01/25/2011 | CA2174098C Method of inducing and maintaining neuronal cells |
| 01/24/2011 | CA2711119A1 System and method for screening liquid compositions |
| 01/20/2011 | WO2011009140A1 Method of assaying 5-fu |
| 01/20/2011 | WO2011009137A1 System and method for analyzing samples labeled with 5, 10, 15, 20 tetrakis (4-carboxyphenyl) porphine (tcpp) |
| 01/20/2011 | WO2011009132A2 Methods and composition for isoprenoid diphosphate synthesis |
| 01/20/2011 | WO2011009104A1 Nucleic acid analysis |
| 01/20/2011 | WO2011009089A1 SMALL NON-CODING REGULATORY RNAs AND METHODS FOR THEIR USE |
| 01/20/2011 | WO2011009077A2 Labeled skin lesion biopsy punch and uses thereof |
| 01/20/2011 | WO2011009052A2 Electroactivated peptides and biosensors |
| 01/20/2011 | WO2011008996A2 Peptides whose uptake in cells is controllable |
| 01/20/2011 | WO2011008992A2 Peptides whose uptake in cells is controllable |
| 01/20/2011 | WO2011008990A1 Drug selection for gastric cancer therapy using antibody-based arrays |
| 01/20/2011 | WO2011008970A1 Methods for diagnosing chronic diarrhea through protein secretion analysis |
| 01/20/2011 | WO2011008947A2 Treatment and diagnosis of immune disorders |
| 01/20/2011 | WO2011008926A2 Zinc oxide sulfur sensor |
| 01/20/2011 | WO2011008912A1 Novel fluorescent dyes and uses thereof |
| 01/20/2011 | WO2011008907A2 Method for estimating properties of concrete |
| 01/20/2011 | WO2011008850A2 H3k27me3 and cancer |
| 01/20/2011 | WO2011008831A2 Mass tags for spectrometric analysis of immunoglobulins |
| 01/20/2011 | WO2011008785A2 A method of analyzing cellulose decay in cellulosic material hydrolysis |
| 01/20/2011 | WO2011008780A1 Apparatus and methods for processing a whole blood sample |
| 01/20/2011 | WO2011008743A2 Flame safety system for in situ process analyzer |
| 01/20/2011 | WO2011008581A2 Devices, methods, and kits for determining analyte concentrations |
| 01/20/2011 | WO2011008520A2 Analyte testing methods and device for calculating basal insulin therapy |
| 01/20/2011 | WO2011008518A2 Methods and apparatus for the detection and differentiation of non-sialated proteins from sialated proteins in a fluid sample |
| 01/20/2011 | WO2011008517A2 Immunoglobulin fc polypeptides |
| 01/20/2011 | WO2011008262A2 Methods and apparatus for diagnosis and/or prognosis of cancer |
| 01/20/2011 | WO2011008249A1 Tube for separating portions of a sample |
| 01/20/2011 | WO2011008173A1 Improved screening of biopolymers |
| 01/20/2011 | WO2011008030A2 Chromatographic system for nucleic acid detection |
| 01/20/2011 | WO2011007936A1 Diagnostic method for fetal neurological disorders due to maternal epilepsy and screening method for therapeutic agents therefor |
| 01/20/2011 | WO2011007876A1 Nucleic acid molecule capable of binding to hmgb1, and use thereof |
| 01/20/2011 | WO2011007857A1 Support for electrophoresis and method for separating and analyzing component of living organism using same |
| 01/20/2011 | WO2011007823A1 Prognosis diagnosis method and prognosis diagnosis kit for sepsis or multiple organ failure |
| 01/20/2011 | WO2011007797A1 Method for measurement of glycoprotein, method for detection of hepatic diseases, reagent for quantification of glycoprotein, and sugar chain marker glycoprotein as measure of disease conditions of hepatic diseases |
| 01/20/2011 | WO2011007773A1 Mutant ras polypeptide crystal |
| 01/20/2011 | WO2011007764A1 Sugar chain marker as measure of disease conditions of hepatic diseases |
| 01/20/2011 | WO2011007743A1 Method for specific cleavage of n-cα bond in peptide main chain |
| 01/20/2011 | WO2011007514A1 Analysis reagent and analysis device having the analysis reagent carried therein |
| 01/20/2011 | WO2011007374A1 Method and apparatus for identifying the orientation of wood fibres |
| 01/20/2011 | WO2011007337A2 Cosmetic use of lacritin-type polypeptides |
| 01/20/2011 | WO2011007314A1 IMIDAZO[1,2-α]PYRAZIN-3(7H)-ONE DERIVATIVES BEARING A NEW ELECTRON-RICH STRUCTURE |
| 01/20/2011 | WO2011007290A2 Multiple component materials having a color-changing composition |
| 01/20/2011 | WO2011007280A2 Measuring molecular contamination in vacuum environments |
| 01/20/2011 | WO2011007259A2 New tool for studying endothelial haematopoietic transition (eht) and epithelial-mesenchymal transition (emt) associated events |
| 01/20/2011 | WO2011007209A1 Cleaved and phosphorylated crmp2 as blood marker of inflammatory diseases of the central nervous system |
| 01/20/2011 | WO2011007205A1 Temperature-compensated in-vivo sensor |
| 01/20/2011 | WO2011007180A1 Immunodetection and quantification of pyrazolopyrimidine sedatives |